Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2008;102:1239-1246
Published online before print April 10, 2008, doi: 10.1161/CIRCRESAHA.107.167544
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Data Supplement
Right arrow All Versions of this Article:
102/10/1239    most recent
CIRCRESAHA.107.167544v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boyd, J. H.
Right arrow Articles by Walley, K. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boyd, J. H.
Right arrow Articles by Walley, K. R.
Related Collections
Right arrow Contractile function
Right arrow Other myocardial biology
Right arrow Other heart failure
Right arrow Animal models of human disease
Right arrowRelated Article
(Circulation Research. 2008;102:1239.)
© 2008 American Heart Association, Inc.


Cellular Biology

S100A8 and S100A9 Mediate Endotoxin-Induced Cardiomyocyte Dysfunction via the Receptor for Advanced Glycation End Products

John H. Boyd, Bernard Kan, Haley Roberts, Yingjin Wang, Keith R. Walley

From the Critical Care Research Laboratories, St. Paul’s Hospital, University of British Columbia, Vancouver, Canada.

Correspondence to John H. Boyd, MD, Critical Care Research Laboratories, 1081 Burrard St, Vancouver, BC, Canada V6Z 1Y6. E-mail jboyd{at}mrl.ubc.ca

Cardiovascular dysfunction as a result of sepsis is the leading cause of death in the critically ill. Cardiomyocytes respond to infectious pathogens with a Toll-like receptor–initiated proinflammatory response in conjunction with a decrease in contractility, although the downstream events linking Toll-like receptor activation and reduced cardiac contractility remain to be elucidated. Using microarray analysis of cardiac tissue exposed to systemic lipopolysaccharide (LPS), we discovered that 2 small calcium-regulating proteins (S100A8 and S100A9) are highly upregulated. HL-1 cardiomyocytes, isolated primary cardiomyocytes, and live mice were exposed to LPS, whereas beating HL-1 cells had S100A8 and S100A9 overexpressed and their calcium flux quantified. Using in vivo microbubble technology, we delivered S100A8 and S100A9 to normal mouse hearts; using the same technology, we inhibited S100A9 production in mouse hearts and subsequently exposed them to LPS. Coimmunoprecipitation of S100A8 and S100A9 identified interaction with RAGE (the receptor for advanced glycation end products), the cardiac function and postreceptor signaling of which were investigated. HL-1 cardiomyocytes, isolated primary cardiomyocytes, and whole hearts exposed to LPS have large increases in S100A8 and S100A9. Cardiac overexpression of S100A8 and S100A9 led to a RAGE-dependent decrease in calcium flux and, in the intact mouse, to a decreased cardiac ejection fraction, whereas knockdown of S100A9 attenuated LPS-induced cardiac dysfunction. Cardiomyocytes exposed to LPS express S100A8 and S100A9, leading to a RAGE-mediated decrease in cardiomyocyte contractility. This finding provides a novel mechanistic link between circulating pathogen-associated molecular products and subsequent cardiac dysfunction.


Key Words: S100 proteins • RAGE • ventricular contractility


Related Article:

Cardiac RAGE in Sepsis: Call TOLL Free for Anti-RAGE
Giora Z. Feuerstein
Circ. Res. 2008 102: 1153-1154. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
S. Y. Lim, M. J. Raftery, J. Goyette, K. Hsu, and C. L. Geczy
Oxidative modifications of S100 proteins: functional regulation by redox
J. Leukoc. Biol., September 1, 2009; 86(3): 577 - 587.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
R. Ramasamy, S. F. Yan, and A. M. Schmidt
RAGE: therapeutic target and biomarker of the inflammatory response--the evidence mounts
J. Leukoc. Biol., September 1, 2009; 86(3): 505 - 512.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Croce, H. Gao, Y. Wang, T. Mooroka, M. Sakuma, C. Shi, G. K. Sukhova, R. R.S. Packard, N. Hogg, P. Libby, et al.
Myeloid-Related Protein-8/14 Is Critical for the Biological Response to Vascular Injury
Circulation, August 4, 2009; 120(5): 427 - 436.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
L. Chung, A. E. Nelson, K. K. Y. Ho, and R. C. Baxter
Proteomic Profiling of Growth Hormone-Responsive Proteins in Human Peripheral Blood Leukocytes
J. Clin. Endocrinol. Metab., August 1, 2009; 94(8): 3038 - 3043.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. Sinha, C. Okoro, D. Foell, H. H. Freeze, S. Ostrand-Rosenberg, and G. Srikrishna
Proinflammatory S100 Proteins Regulate the Accumulation of Myeloid-Derived Suppressor Cells
J. Immunol., October 1, 2008; 181(7): 4666 - 4675.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
O. Turovskaya, D. Foell, P. Sinha, T. Vogl, R. Newlin, J. Nayak, M. Nguyen, A. Olsson, P. P. Nawroth, A. Bierhaus, et al.
RAGE, carboxylated glycans and S100A8/A9 play essential roles in colitis-associated carcinogenesis
Carcinogenesis, October 1, 2008; 29(10): 2035 - 2043.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
G. Z. Feuerstein
Cardiac RAGE in Sepsis: Call TOLL Free for Anti-RAGE
Circ. Res., May 23, 2008; 102(10): 1153 - 1154.
[Full Text] [PDF]